%PDF-1.4
%
40 0 obj
<>
endobj
37 0 obj
<>
endobj
91 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-12-03T10:10:26Z
2024-03-29T09:02-07:00
QuarkXPressª: AdobePS 8.6 (219)
2024-03-29T09:02-07:00
application/pdf
Heather
2001-226.feb
uuid:5a294894-1dd2-11b2-0a00-9d08275dc400
uuid:5a294896-1dd2-11b2-0a00-810000000000
endstream
endobj
26 0 obj
<>
endobj
27 0 obj
<>
endobj
41 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Type/Page>>
endobj
9 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
12 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
105 0 obj
[109 0 R]
endobj
106 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.06 612 -792 re
W n
BT
/CS0 cs 0 0 0 1 scn
/GS1 gs
/TT0 1 Tf
-0.00011 Tc 10 0 0 10 54 713.1616 Tm
(REFERENCES)Tj
/TT1 1 Tf
0.02499 Tw 8 0 0 8 61 703.1616 Tm
[(1.)-875.1 (van Leeuwen MA, van der Heijde DMFM, van Rijswijk MH,)]TJ
0 Tc 1.675 -1.25 Td
(Houtman PM, van Riel PL, van de Putte LB. Interrelationship of)Tj
0 -1.25 TD
(outcome measures and process variables in early rheumatoid)Tj
T*
[(arthritis: a comparison of radiologic damage, physical disability)64.9 (,)]TJ
T*
(joint counts, and acute phase reactants. J Rheumatol 1994;21:425-9.)Tj
-1.675 -1.25 Td
[(2.)-875 (Sharp JT)74 (. Radiological assessment as an outcome measure in)]TJ
1.675 -1.25 Td
[(rheumatoid arthritis. )54.9 (Arthritis Rheum 1989;32:221-9.)]TJ
-0.00011 Tc -1.675 -1.25 Td
[(3.)-875.1 (W)79.7 (olfe F)79.7 (. Determinants of )17.7 (WOMAC function, pain and stif)17.7 (fness)]TJ
0 Tc 1.675 -1.25 Td
(scores: evidence for the role of low back pain, symptom counts,)Tj
T*
(fatigue and depression in osteoarthritis, rheumatoid arthritis and)Tj
T*
(fibromyalgia. Rheumatology \(Oxford\) 1999;38:355-61.)Tj
-0.00011 Tc -1.675 -1.25 Td
[(4.)-875.1 (Sokka )17.7 (T)73.9 (,)-0.1 ( Kankainen )54.8 (A, Hannonen P)110.7 (.)-0.1 ( Scores for functional disability)]TJ
0 Tc 1.675 -1.25 Td
(in patients with rheumatoid arthritis are correlated at higher levels)Tj
-0.00011 Tc T*
[(with pain scores than with radiographic scores. )54.8 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(2000;43:386-9.)Tj
0.02499 Tw -1.675 -1.25 Td
[(5.)-875 (Escalante )54.9 (A, del Rincon I. How much disability in rheumatoid)]TJ
1.675 -1.25 Td
[(arthritis is explained by rheumatoid arthritis? )54.8 (Arthritis Rheum)]TJ
0 Tw T*
(1999;42:1712-21.)Tj
0.0249 Tw -1.675 -1.25 Td
[(6.)-875 (Drossaers-Bakker KW)91.8 (, de Buck M, van Zeben D, Zwinderman )54.8 (AH,)]TJ
1.675 -1.25 Td
[(Breedveld FC, Hazes JMW)91.8 (. Long-term course and outcome of)]TJ
T*
[(functional capacity in rheumatoid arthritis. )54.8 (Arthritis Rheum)]TJ
0 Tw T*
(1999;42;1854-60.)Tj
-0.00011 Tc 0.02499 Tw 31.325 27.671 Td
[(7.)-875.1 (Scott DL, Pugner K, Kareela K, Doyle DV)128.8 (, )17.7 (W)79.7 (oolf )54.8 (AD, Holmes J,)]TJ
0 Tc 1.675 -1.25 Td
[(Hieke K. )17.7 (The links between joint damage and disability in)]TJ
T*
(rheumatoid arthritis. Rheumatology \(Oxford\) 2000;39:122-32.)Tj
-0.00011 Tc -1.675 -1.25 Td
[(8.)-875.1 (Pinals RS. Masi )54.8 (A)111 (T)73.9 (, Larsen RA. Preliminary criteria for clinical)]TJ
0 Tc 1.675 -1.25 Td
[(remission in rheumatoid arthritis. )54.8 (Arthritis Rheum 1981;24:)]TJ
0 Tw T*
(1308-15.)Tj
-0.00011 Tc 0.02499 Tw -1.675 -1.25 Td
[(9.)-875.1 (Siegert CEH, )17.7 (Vleming LJ, )17.7 (V)111 (andenbroucke JP)110.7 (, Cats )54.8 (A. Measurement)]TJ
0 Tc 1.675 -1.25 Td
(of disability in Dutch rheumatoid arthritis patients. Clin Rheumatol)Tj
0 Tw T*
(1984;3:305-9. )Tj
0.0249 Tw -2.175 -1.25 Td
[(10.)-875 (V)111.1 (an der Heijde DMFM, van\222)17.8 (t Hof MA, van Riel PLCM, et al.)]TJ
2.175 -1.25 Td
(Judging disease activity in clinical practice in rheumatoid arthritis:)Tj
T*
[(first step in the development of a disease activity score. )54.9 (Ann)]TJ
T*
(Rheum Dis 1990;49:916-20. )Tj
-0.00011 Tc -2.1381 -1.25 Td
[(1)36.8 (1)-0.1 (.)-875.1 (V)111 (an der Heijde DMFM, van Riel PLCM, Nuver)19.7 (-Zwart IH, Gribnau)]TJ
0 Tc 2.1381 -1.25 Td
[(FWJ, van de Putte LBA. Ef)17.8 (fects of hydroxychloroquine and)]TJ
T*
(sulphasalazine on progression of joint damage in rheumatoid)Tj
T*
(arthritis. Lancet 1989;1:1036-8.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(12.)-875.1 (Prevoo MLL, van Gestel )54.8 (AM, van\264t Hof MA, van Rijswijk MH,)]TJ
0 Tc 2.175 -1.25 Td
(van de Putte LBA, van Riel PLCM. Remission in prospective study)Tj
T*
[(of patients with rheumatoid arthritis. )54.9 (American Rheumatism)]TJ
T*
(Association criteria in relation to the disease activity score. Br J)Tj
T*
[(Rheumatol 1996;35:1)36.9 (101-5.)]TJ
ET
/CS0 CS 0 0 0 1 SCN
54 54 m
558 54 l
S
BT
/TT2 1 Tf
8 0 0 8 424.3613 35.9844 Tm
(The Journal of Rheumatology 2002; 29:2)Tj
0 Tw -46.2952 -0.0313 Td
(270)Tj
ET
0 0 0 0 scn
/GS0 gs
101.86 59.75 407.5 -10.83 re
f*
0.5 w
101.86 59.75 407.5 -10.83 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_0 8 Tf
120.092 51 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2002. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_1 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
82 0 obj
<>
endobj
96 0 obj
<>
endobj
53 0 obj
<>
endobj
46 0 obj
<>
endobj
44 0 obj
<>
endobj
43 0 obj
<>
endobj
72 0 obj
<>stream
HVPTι"bzW6Y/4+ADvUƤZ;6AkĎNZڌuT1Fw|%3q݅ P?̞
.vLqErwB.EXQ\P?sq,m_ڀ\dG3,.|1F$Jv\=xo9Q59uM@38;s(GUUFȷW3x(I"~s,nӂr~i_s2!jEвRD:G\#nP/4\؏EXh@7!U Q+،Ua3v/6"Tq*V^b02vƣ eu
=.NOTZH//*5N1+aVpTכXsOp 1'&hjYWBC2p`d)m`_\Qb*J8$NKVV)uI&a yO4x:uxwD*zU&d+oUE]^HvJ!!Q oػ
d(;sMBN!LFA~_2ZICte2W=^Ѽ*Y2<ܮ+J%̽^c9j7lʓ?q
y
$&]5ޥsrRĎ q?.mt֭"#MU@fTSݶl<:U??gO<=͞Ǟ"FAkCoE|\1
u)^a
;toByn
5sʃ^5F+w
kmG6XZFhmJ7Pbys:\SdM̶-ÑMgfh} kb0ݟUb&L%Ph.7rׯ$<k[_hʔ@i0Y3YR`-/)WLuM9Rkkt3fgYĠ]=Լzpp/u2
9I=zg-Ƅe],Y{{=t%,kYj_KG\5a1F0S/Ig0,_iYtP3l0f]S-%Ѓ?m4n> h)1?^~|ah6ʹ4)eHmHXǝQev2*ctK|1P8 uw얭i`:zY1nx2M-YblK#~qbfD㿶1qL?̥amu DvF$(Z"z~/"_,\G-9cX
uZJ*ߺeD<љD21DDdrO-18gԟpNe9ls&\;d5q}_[K;,ZIYgݢ=ZGk?e3K81nRF
?RqBtSag"EGO⺀\}UXvnMhMi"CQ%ٺ.^=uZ>lm(0fN?4QdO?Q漙@Tcf/Uqu7cvνNH4L81VaKW>R $EmAHh%7| JN҄LFﹳL4Kw=w;DI
-azZr%B=Y4rH ?,KN7AۅuD-"4 -M
NJ&